Association of FTO, LEPR and MTHFR gene polymorphisms with metabolic syndrome in schizophrenia patients receiving antipsychotics
Aim: The occurrence of metabolic syndrome (MS) in schizophrenia patients receiving long-term antipsychotics (APs) contributes to their high mortality rate. We aimed to determine whether genetic polymorphisms of identified candidate genes are associated with MS in our study population. Materials &...
Saved in:
Main Authors: | Roffeei, S.N., Mohamed, Z., Reynolds, G.P., Said, M.A., Hatim, A., Mohamed, E.H.M., Aida, S.A., Zainal, N.Z. |
---|---|
Format: | Article |
Published: |
2014
|
Subjects: | |
Online Access: | http://eprints.um.edu.my/10965/ http://www.futuremedicine.com/doi/abs/10.2217/pgs.13.220 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Association of ADRA2A and MTHFR gene polymorphisms with weight loss following antipsychotic switching to aripiprazole or ziprasidone
by: Roffeei, S.N., et al.
Published: (2014) -
Metabolic syndrome and antipsychotic monotherapy treatment among schizophrenia patients in Malaysia
by: Said, M.A., et al.
Published: (2013) -
Metabolic syndrome and cardiovascular risk among patients with schizophrenia receiving antipsychotics in Malaysia
by: Said, Mas Ayu, et al.
Published: (2012) -
Atypical antipsychotic Lumateperone beyond Schizophrenia: seeking clarity in a time of uncertainty
by: Mohamed, Wael Mohamed Yousef
Published: (2022) -
Effects of nicotine on Schizophrenia and antipsychotic
medications: a systematic review
by: Hamdan, Hamira Farahana, et al.
Published: (2018)